Sepsis News

• Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1 The FDA advisory committee's 8-7 vote favoring approval of terlipressin for hepatorenal syndrome type 1 reflected concerns and misgivings.
  Medscape Medical News, July 16, 2020
• COVID-19 Update: Possible PPI Risk, Co-Infection in Hospital These are the coronavirus stories you need to know about today.
  Medscape Medical News, July 09, 2020
• Collateral Damage: Delayed Diagnoses in Kids During COVID-19 Survey reveals 50% drop in child visits to emergency departments and the most common delayed diagnosis was type 1 diabetes. The consequences are greater than the risks of COVID-19 in kids, say experts.
  Medscape Medical News, July 08, 2020
• Even a Few Days of Steroids May Be Risky, New Study Suggests Clinicians often prescribe a short course of oral steroids for self-limiting conditions, but a growing body of data suggests such treatments are tied to severe adverse events.
  Medscape Medical News, July 08, 2020
• Gene Therapy Trial Halted After Second Patient Death A clinical trial of Audentes Therapeutics' investigational gene therapy for X-linked myotubular myopathy is on hold after two patients died following receipt of a high dose of the drug.
  Medscape Medical News, June 29, 2020
• ASCO 2020Treatments Linked to Death in COVID Patients With Thoracic Cancers Past treatment may affect the risk of death among patients with thoracic malignancies who develop COVID-19, according to data from the TERAVOLT registry.
  Medscape Medical News, June 29, 2020
• EHA 2020Venetoclax Plus LDAC Tops LDAC Alone in AML Cytarabine plus venetoclax showed benefit in overall survival for treatment naive AML patients.
  Medscape Medical News, June 29, 2020
• Experts Publish Imaging Recommendations for Pediatric COVID-19 A team of pulmonologists has synthesized the clinical and imaging characteristics of COVID-19 in children, and has devised recommendations for ordering imaging studies in suspected cases of the infection.
  Medscape Medical News, June 26, 2020
• Insurers and States Move to Lower Malpractice Premiums; More The goal is to reduce med-mal premiums during the pandemic; nursing home disaster triggers a class action; pneumonia patient dies on hospital's watch, suit claims.
  Medscape Business of Medicine, June 24, 2020
• Alert FDA Approves First Drug for Adult-Onset Still's Disease The FDA has expanded the indications for canakinumab (Ilaris) to include all patients with active Still’s disease older than 2 years.
  FDA Approvals, June 19, 2020
• More Questions Than Answers About MIS-C, Experts Say Every case of pediatric multisystem inflammatory syndrome associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C) adds further detail to a still unclear clinical picture.
  Medscape Medical News, June 16, 2020
• COVID-19 Update: HCQ Study Questioned, Protests and Outbreaks These are the coronavirus stories you need to know about today.
  Medscape Medical News, June 01, 2020
• Controversy Remains Over Corticosteroids in COVID-19 The most commonly invoked rationale for giving steroids in patients with severe COVID-19 is to modulate the destructive inflammatory immune response that occurs with advancing disease.
  Medscape Medical News, June 01, 2020
• Severe Disease Not Uncommon in Kids Hospitalized With COVID-19 The rate of severe COVID-19 requiring pediatric intensive care admission among hospitalized children was higher than previous data suggested, researchers found.
  Medscape Medical News, May 27, 2020
• Can Nitric Oxide Prevent COVID-19 Infection or Progression? Dr Lorenzo Berra, a Boston anesthesiologist and intensivist, discusses nitric oxide and its use in treating patients who are infected with COVID-19.
  Medscape Medical News, May 26, 2020
• A Long Road to Recovery: Lung Rehab Needed After COVID-19 Experts discuss the potential for long-term lung and organ damage after severe COVID-19 and emphasize need for rehabilitation to treat weakness and psychological concerns from prolonged ICU stays.
  Medscape Medical News, May 26, 2020
• Shorter Course of Antibiotics Just as Effective for Kids With Pyelonephritis Treating children with pyelonephritis with antibiotics for six to nine days may work just as well as treating them for 10 days or longer, a recent study suggests.
  Reuters Health Information, May 22, 2020
• Cases of Children With Rare Inflammatory Syndrome Spike in Italy and France Doctors in France and northern Italy have reported spikes in cases of a rare inflammatory syndrome in young children that appears similar to one reported in the United States, Britain and Spain.
  Reuters Health Information, May 14, 2020
• Life After COVID-19: The Road to Recovery Doctors are just starting to learn what recovery from COVID-19 looks like and whether it will cause long-term damage to its survivors, both physically and mentally.
  WebMD Health News, May 14, 2020
• Chinese Researchers Develop COVID-19 Risk Score to Predict Severe Disease Researchers in China have developed and validated a COVID-19 risk score that may help predict at the time of admission a patient's risk of progressing to severe disease.
  Reuters Health Information, May 13, 2020